Toronto Innovation Acceleration Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Radiant Biotherapeuticsradiantbio.cominAug 2024
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.